Trexquant Investment’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15,806
| Closed | -$509K | – | 1570 |
|
|
2024
Q2 | $509K | Sell |
15,806
-92,421
| -85% | -$2.98M | 0.01% | 1242 |
|
|
2024
Q1 | $4.2M | Buy |
108,227
+13,650
| +14% | +$530K | 0.08% | 370 |
|
|
2023
Q4 | $2.91M | Sell |
94,577
-38,402
| -29% | -$1.18M | 0.07% | 432 |
|
|
2023
Q3 | $2.97M | Buy |
132,979
+32,680
| +33% | +$730K | 0.07% | 370 |
|
|
2023
Q2 | $2.16M | Sell |
100,299
-15,428
| -13% | -$332K | 0.06% | 472 |
|
|
2023
Q1 | $2.78M | Buy |
115,727
+105,323
| +1,012% | +$2.53M | 0.08% | 349 |
|
|
2022
Q4 | $241K | Buy |
+10,404
| New | +$241K | 0.01% | 1177 |
|
|
2021
Q4 | – | Sell |
-18,549
| Closed | -$366K | – | 1348 |
|
|
2021
Q3 | $366K | Buy |
+18,549
| New | +$366K | 0.03% | 660 |
|
|
2021
Q2 | – | Sell |
-20,174
| Closed | -$478K | – | 1147 |
|
|
2021
Q1 | $478K | Buy |
+20,174
| New | +$478K | 0.04% | 527 |
|
|
2019
Q3 | – | Sell |
-11,316
| Closed | -$149K | – | 895 |
|
|
2019
Q2 | $149K | Sell |
11,316
-18,669
| -62% | -$246K | 0.01% | 714 |
|
|
2019
Q1 | $454K | Sell |
29,985
-3,096
| -9% | -$46.9K | 0.03% | 606 |
|
|
2018
Q4 | $568K | Sell |
33,081
-1,111
| -3% | -$19.1K | 0.04% | 577 |
|
|
2018
Q3 | $504K | Buy |
+34,192
| New | +$504K | 0.04% | 536 |
|
|
2018
Q2 | – | Sell |
-23,534
| Closed | -$601K | – | 945 |
|
|
2018
Q1 | $601K | Buy |
+23,534
| New | +$601K | 0.04% | 579 |
|
|
2017
Q2 | – | Sell |
-25,705
| Closed | -$259K | – | 837 |
|
|
2017
Q1 | $259K | Buy |
+25,705
| New | +$259K | 0.03% | 835 |
|